Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane O-methyltransferase (TOMT) is a transmembrane enzyme localized primarily in the Golgi apparatus, and forms part of the auditory hair cell mechanotransduction (MET) complex responsible for converting acoustic mechanical signals into electrical activity within the cochlea. TOMT interacts directly with proteins such as TMC1 and TMC2 and is essential for trafficking and functional assembly of these channels at the stereocilia tips of hair cells. In contrast to classical catechol-O-methyltransferase (COMT), TOMT may lack significant catechol methyltransferase activity in vivo and appears to have evolved a unique, non-classical role specific to auditory physiology. Variants in the TOMT gene cause autosomal recessive nonsyndromic deafness, highlighting its essentiality for hearing but TOMT is currently not a recognized pharmacological target for approved drugs[1][2][5].
For hair cell mechanotransduction: Facilitates TMC1 and TMC2 trafficking to stereocilia, independent of classic O-methyltransferase function. Enzymatic methylation of catechols is not physiologically significant in mammalian TOMT.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane O-methyltransferase (TOMT).